Cargando…

Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer

Detalles Bibliográficos
Autor principal: Oncology, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632053/
https://www.ncbi.nlm.nih.gov/pubmed/37946722
http://dx.doi.org/10.1155/2023/9807856
_version_ 1785132494661615616
author Oncology, Journal of
author_facet Oncology, Journal of
author_sort Oncology, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10632053
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-106320532023-11-09 Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer Oncology, Journal of J Oncol Retraction Hindawi 2023-11-01 /pmc/articles/PMC10632053/ /pubmed/37946722 http://dx.doi.org/10.1155/2023/9807856 Text en Copyright © 2023 Journal of Oncology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Oncology, Journal of
Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
title Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
title_full Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
title_fullStr Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
title_full_unstemmed Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
title_short Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
title_sort retracted: il2rb is a prognostic biomarker associated with immune infiltrates in pan-cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632053/
https://www.ncbi.nlm.nih.gov/pubmed/37946722
http://dx.doi.org/10.1155/2023/9807856
work_keys_str_mv AT oncologyjournalof retractedil2rbisaprognosticbiomarkerassociatedwithimmuneinfiltratesinpancancer